Canandaigua National Bank & Trust’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.4M Buy
13,852
+11,465
+480% +$1.31M 0.12% 150
2026
Q2
$282K Buy
+2,387
New +$276K 0.02% 278
2025
Q4
– Sell
-1,413
Closed -$208K – 324
2025
Q3
$208K Buy
+1,413
New +$196K 0.02% 313
2020
Q1
$288K Sell
4,418
-76
-2% -$5.99K 0.06% 188
2019
Q4
$354K Sell
4,494
-420
-9% -$32.7K 0.06% 198
2019
Q3
$391K Sell
4,914
-6
-0.1% -$471 0.07% 182
2019
Q2
$412K Sell
4,920
-169
-3% -$13.5K 0.08% 180
2019
Q1
$402K Sell
5,089
-547
-10% -$39.9K 0.08% 177
2018
Q4
$376K Sell
5,636
-400
-7% -$27.7K 0.08% 171
2018
Q3
$482K Sell
6,036
-55
-0.9% -$4.11K 0.09% 166
2018
Q2
$410K Buy
+6,091
New +$442K 0.08% 186

Other funds holding XYL

Canandaigua National Bank & Trust's XYL Position: Q3 2026 in Review

Canandaigua National Bank & Trust increased its Xylem (XYL) stake by 480% in Q3 2026, buying an estimated $1.31M and bringing the position to 13,852 shares worth $1.4M. The position accounts for 0.12% of the portfolio, ranked #150.

Canandaigua National Bank & Trust first reported a position in XYL in Q2 2018 and has held it in 11 quarters since. 34 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Canandaigua National Bank & Trust held 13,852 shares of Xylem worth $1.4M as of Q3 2026.
  • Canandaigua National Bank & Trust bought 11,465 Xylem shares in Q3 2026, an estimated $1.31M.
  • Xylem made up 0.12% of Canandaigua National Bank & Trust's portfolio in Q3 2026, its #150 holding.
  • Canandaigua National Bank & Trust first reported a position in Xylem in Q2 2018 and has held it in 11 quarters since.
  • 34 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.